Petmed Express’s Neutral Rating Reaffirmed at Zacks (PETS)
Petmed Express (NASDAQ:PETS)‘s stock had its “neutral” rating restated by Zacks in a research note issued on Friday. They currently have a $15.00 price objective on the stock. Zacks‘s price target would suggest a potential upside of 6.76% from the stock’s previous close.
Zacks’ analyst wrote, “PetMed’s EPS of $0.25 during the first quarter of fiscal 2015 was $0.01 higher than the year-ago figure but was in line with the Zacks Consensus Estimate. Net sales dropped 2.2% but coincided with the estimate. Although we are encouraged by the company’s efforts to revive the top line, lower new order and re-order sales was a drag. Moreover, increasing product costs and discounts pressurized margins. The company continues to face competition which may increase further with the impending acquisition of Novartis’ animal health by Eli Lilly. The dearth of any near-term catalyst might make it difficult for PetMed to overcome these challenges. Accordingly, we are Neutral on PetMed.”
Petmed Express (NASDAQ:PETS) traded up 0.61% on Friday, hitting $14.04. The stock had a trading volume of 162,713 shares. Petmed Express has a one year low of $12.13 and a one year high of $17.21. The stock’s 50-day moving average is $13.52 and its 200-day moving average is $13.48. The company has a market cap of $280.3 million and a P/E ratio of 15.34.
Petmed Express (NASDAQ:PETS) last issued its quarterly earnings data on Monday, July 21st. The company reported $0.25 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.25. The company had revenue of $72.50 million for the quarter, compared to the consensus estimate of $74.25 million. During the same quarter in the prior year, the company posted $0.24 earnings per share. The company’s quarterly revenue was down 2.3% on a year-over-year basis. Analysts expect that Petmed Express will post $0.91 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, August 15th. Shareholders of record on Monday, August 4th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 4.84%. The ex-dividend date is Thursday, July 31st.
Separately, analysts at Northcoast Research downgraded shares of Petmed Express from a “buy” rating to a “neutral” rating in a research note on Thursday, May 1st.
PetMed Express, Inc (NASDAQ:PETS) and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.